This simulation study using a mathematical model of pertussis transmission assesses whether a priming dose of whole-cell pertussis vaccine is cost-effective at reducing pertussis infection in infants.
This study evaluates the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine’s effect over time among adolescents 11 to 18 years old and accounts for the transition from whole-cell to acellular pertussis vaccines for the childhood primary series.
This review provides an overview of measles, including information on virus basics, clinical picture and diagnosis, complications, vaccine efficacy, and vaccine complications.
Rowhani-Rahbar et al examine the potential modifying effect of age on the risk of fever and seizures following immunization with measles-containing vaccines.
Stockwell and coauthors compare fever rates in children receiving trivalent inactivated influenza vaccine and 13-valent pneumococcal vaccine and those receiving either product without the other.
This study provides estimates of the effects of a grandfather clause in a California state law on nonmedical vaccine exemptions in California’s schools
This cohort study found an increase in adverse events after immunization of extremely low-birth-weight infants in the neonatal intensive care unit.
This review study found that most practice- and community-based interventions significantly increased human papillomavirus vaccination rates across diverse populations.
In a matched case-control study with conditional logistic regression analysis, Glanz and coauthors examine the association between undervaccination and pertussis in children 3 to 36 months of age.